Katarzyna Wilk

No ORCID on file · 4 papers in corpus · active 2021-2025

Study types

  • article 3
  • other 1

Condition tags

  • dysmenorrhea 3
  • endometriosis 3
  • dyspareunia 2
  • chronic_pelvic_pain 1
  • adenomyosis 1
other 2025
Prevalence of adenomyosis in adolescents: diagnostic process and symptoms. Systematic review
Ginekologia polska ·doi:10.5603/gpl.103105

BACKGROUND: Adenomyosis is a uterine disorder commonly associated with painful menstrual cycles, abnormal uterine bleeding, and dyspareunia, which can significantly impact fertility, pregnancy outcomes and overall quality of life. Recent li…

article 2024
P-308 Relugolix combination therapy vs relugolix monotherapy with transition to relugolix combination therapy for the treatment of endometriosis-associated pain: implications for cumulative benefit/risk profile
·doi:10.1093/humrep/deae108.273

Abstract Study question How does the benefit/risk profile compare in women with endometriosis-associated pain who initiated relugolix combination therapy (Relugolix-CT) vs relugolix monotherapy with transition to Relugolix-CT? Summary answe…

article 2021
O-132 Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data
·doi:10.1093/humrep/deab126.057

Abstract Study question To assess the long-term (52-week) efficacy and safety of relugolix combination therapy (Relugolix-CT) in the treatment of endometriosis-associated pain. Summary answer Relugolix-CT demonstrated a sustained improvemen…

article 2021
Sustained Efficacy and Safety of Relugolix Combination Therapy in Women with Endometriosis-Associated Pain: Spirit 52-Week Data
·doi:10.1016/j.jmig.2021.09.031